NCT05284890View on ClinicalTrials.gov

A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

July 11, 2022

Study Completion Date

July 11, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

CC-99677

Specified dose on specified days

Trial Locations (1)

53704-2526

Local Institution - 0001, Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05284890 - A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants | Biotech Hunter | Biotech Hunter